People · Operator

Jerry Galwns

Named in public records as an officer, director or promoter · active 2014–2014 · Other Health Care

1
Companies
1
Filings
$52.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NOWDiagnostics, Inc.Other Health CareSeries B$52.3M$420.4M2014
Operator network

Jerry Galwns at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Clete Brewer · 8 companies · 1 sharedClete BrewerAlan Chang · 4 companies · 1 sharedAlan ChangKevin Clark · 4 companies · 1 sharedKevin ClarkJeremy Wilson · 3 companies · 1 sharedJeremy WilsonChuck Farkas · 2 companies · 1 sharedChuck FarkasDoug Degn · 2 companies · 1 sharedDoug DegnAnn Bordelon · 1 companies · 1 sharedAnn BordelonCharles B. Farkas · 1 companies · 1 sharedCharles B. FarkasDoug B. Degn · 1 companies · 1 sharedDoug B. DegnGerald Gallwas · 1 companies · 1 sharedGerald GallwasGerald Galwas · 1 companies · 1 sharedGerald GalwasJeff B. Montie · 1 companies · 1 sharedJeff B. MontieJeff Montie · 1 companies · 1 sharedJeff MontieJohn B. Harley · 1 companies · 1 sharedJohn B. HarleyJohn Harley · 1 companies · 1 sharedJohn HarleyQinwei Shi · 1 companies · 1 sharedQinwei ShiNOWDiagnostics, Inc. · $52.3M raisedNOWDiagnostics, Inc.Jerry GalwnsJG
Jerry Galwns Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jerry Galwns on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Clete Brewer18
Kevin Clark14
Alan Chang14
Jeremy Wilson13
Doug Degn12
Chuck Farkas12
Jeff Montie11
Ann Bordelon11
Doug B. Degn11
Gerald Gallwas11
John Harley11
Charles B. Farkas11
John B. Harley11
Jeff B. Montie11
Qinwei Shi11
Gerald Galwas11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.